JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, vol.310, no.11, pp.1145-1155, 2013 (SCI-Expanded)
IMPORTANCE The optimal anticoagulant for patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) managed with an invasive strategy remains controversial.